{"title":"Successful switching to Infliximabafter systemic allergic reaction toAdalimumab drug: a case report","authors":"A. Sadeghi","doi":"10.37532/1758-4272.2021.16(5).158","DOIUrl":null,"url":null,"abstract":"Subjective: To describe a case of systemic allergic reaction to Adalimumab drug in an Ankylosing Spondylitis (AS) patient and switching to Infliximab. Case report: A 43-year-old middleeastern man with a history of AS who was initiated with the treatment of Adalimumab. After the second injection of the drug immediate systemic allergic reaction with the symptoms of dizziness, shortness of the breath, angioedema of the limps and generalized rashes and itching happened. Discussion: Systemic reactions to Adalimumab although rare have been reported before. In case of allergic reaction to this drug desensitization and switching to another anti-TNFα have been successfully tried.","PeriodicalId":13740,"journal":{"name":"International Journal of Clinical Rheumatology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37532/1758-4272.2021.16(5).158","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Subjective: To describe a case of systemic allergic reaction to Adalimumab drug in an Ankylosing Spondylitis (AS) patient and switching to Infliximab. Case report: A 43-year-old middleeastern man with a history of AS who was initiated with the treatment of Adalimumab. After the second injection of the drug immediate systemic allergic reaction with the symptoms of dizziness, shortness of the breath, angioedema of the limps and generalized rashes and itching happened. Discussion: Systemic reactions to Adalimumab although rare have been reported before. In case of allergic reaction to this drug desensitization and switching to another anti-TNFα have been successfully tried.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
